CaMKII is a RIP3 substrate mediating ischemia-and oxidative stress–induced myocardial necroptosis T Zhang, Y Zhang, M Cui, LI Jin, Y Wang, F Lv, Y Liu, W Zheng, H Shang, ... Nature medicine 22 (2), 175-182, 2016 | 682 | 2016 |
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders R Song, W Peng, Y Zhang, F Lv, HK Wu, J Guo, Y Cao, Y Pi, X Zhang, ... Nature 494 (7437), 375-379, 2013 | 293 | 2013 |
Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis J Dai, K Liang, S Zhao, W Jia, Y Liu, H Wu, J Lv, C Cao, T Chen, ... Proceedings of the National Academy of Sciences 115 (26), E5896-E5905, 2018 | 240 | 2018 |
Glucose-sensitive myokine/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis HK Wu, Y Zhang, CM Cao, X Hu, M Fang, Y Yao, L Jin, G Chen, P Jiang, ... Circulation 139 (7), 901-914, 2019 | 89 | 2019 |
Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H2O2-Activated Protein Kinase C-δ Signaling D Shan, S Guo, HK Wu, F Lv, L Jin, M Zhang, P Xie, Y Wang, Y Song, ... Circulation 142 (11), 1077-1091, 2020 | 35 | 2020 |
MG53: biological function and potential as a therapeutic target Y Zhang, HK Wu, F Lv, RP Xiao Molecular pharmacology 92 (3), 211-218, 2017 | 32 | 2017 |
MG53 is a double-edged sword for human diseases. Y Zhang, HK Wu, FX Lv, RP Xiao Sheng li xue bao:[Acta physiologica Sinica] 68 (4), 505-516, 2016 | 13 | 2016 |
MG53 E3 Ligase–Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage H Feng, H Shen, MJ Robeson, YH Wu, HK Wu, GJ Chen, S Zhang, P Xie, ... Diabetes 71 (2), 298-314, 2022 | 12 | 2022 |
Physiological evidence of mitochondrial permeability transition pore opening caused by lipid deposition leading to hepatic steatosis in db/db mice HS Yuan Li, Jing Wu, Min Yang, Lisi Wei, Hongkun Wu, Qinyi Wang FREE RADICAL BIOLOGY AND MEDICINE 162, 523-532, 2021 | 10 | 2021 |
C14a Mutation Abolishes Mg53-Aggravated Glucose Metabolic Dysfunction and Exerts a Dominant Therapeutic Target for Ischemia and Reperfusion (i/r) Injury in Diabetic Heart H Feng, H Shen, MJ Robeson, H Wu, G Chen, S Zhang, F Lv, X Hu, ... Circulation 142 (Suppl_3), A14197-A14197, 2020 | | 2020 |
Response by Wu et al to Letter Regarding Article,“Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis” HK Wu, Y Zhang, G Chen, X Hu, F Lv, RP Xiao Circulation 140 (6), e188-e189, 2019 | | 2019 |